Chargement en cours...
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery
BACKGROUND: The off-label use of recombinant activated factor VII (rFVIIa) for intractable bleeding is associated with a risk of thrombotic events. The objective of this study was to evaluate the incidence and predictors of rFVIIa-related thrombotic events and its efficacy in the reduction of transf...
Enregistré dans:
| Publié dans: | Drugs R D |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488183/ https://ncbi.nlm.nih.gov/pubmed/25862216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-015-0093-9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|